Last reviewed · How we verify
Gan Fu Le Tablets — Competitive Intelligence Brief
phase 3
Hepatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Gan Fu Le Tablets (Gan Fu Le Tablets) — Shenzhen Kangzhe Pharmaceutical Co., Ltd.. Gan Fu Le Tablets is a traditional Chinese medicine formulation designed to support liver function and promote hepatic health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Gan Fu Le Tablets TARGET | Gan Fu Le Tablets | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Gan Fu Le Tablets CI watch — RSS
- Gan Fu Le Tablets CI watch — Atom
- Gan Fu Le Tablets CI watch — JSON
- Gan Fu Le Tablets alone — RSS
Cite this brief
Drug Landscape (2026). Gan Fu Le Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/gan-fu-le-tablets. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing